However, we found that when cystic pituitary prolactin-secreting macroadenomas were reduced to a certain extent, even if the maximum safe dose of bromocriptine treatment was maintained, the tumor did not continue to shrink, and the PRL levels of the patients could not be reduced to a normal level. This evidence concerns the gene PRL and neoplasm.